Pfizer Gains European Approval for Amyloidosis Drug Vyndaqel


Sales of the treatment got off to a good start in the U.S., and Europe could follow suit.... Read more

Bron: Fool.com: The Motley Fool
Tags:
Geplaatst: 18 Feb 2020 - 20:24